VRTX vs WS · P/E 30, rev $12.00B vs P/E 16, rev $3.09B
Vertex Pharmaceuticals Inc (VRTX) versus Worthington Steel Inc (WS) — a side-by-side from cached financials, not a winner call.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Worthington Steel Inc (WS) is a steel company listed on NYSE.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Latest reported WS revenue for 2025-05-31 was $3.09B. Net income was $119.3M. Revenue was down 9.8% from 2024-05-31 to 2025-05-31. WS currently screens at market cap $1.99B and trailing P/E 16.3.
VRTX currently screens at market cap $106.87B and trailing P/E 29.7. WS currently screens at market cap $1.99B and trailing P/E 16.3.
Not investment advice. Open the VRTX and WS stock pages for the full models.
Not investment advice.